Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
RetroSense Therapeutics logo — company profile

RetroSense Therapeutics

Founded 2009 1 employees Series B Total: $17.00M Biotechnology, Health and Wellness +1

General Information

Company Name RetroSense Therapeutics
Founded Year 2009
Employees 1
Industries Biotechnology, Health and Wellness, Life Sciences
Funding Stage Series B
Social

BounceWatch is an independent company data service, not affiliated with RetroSense Therapeutics. To contact RetroSense Therapeutics, visit retro-sense.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About RetroSense Therapeutics

RetroSense Therapeutics is a biotechnology startup, with a focus on vision restoration through gene therapy. Founded in 2009 and headquartered in Ann Arbor, Michigan, the company has exclusive rights to relevant intellectual property from Wayne State University and Salus University. Led by a seasoned team, RetroSense employs a novel approach using channelrhodopsin-2, a photosensitivity gene/protein from blue-green algae, to restore light sensitivity in degenerated retinas. With a successful $6.00M Series B investment in 12 November 2015 from ExSight Ventures, BlueWater Angels, RBV Capital, EG Capital Advisors, and Santen Pharmaceutical, the company demonstrates its appeal to a diverse group of investors. Operating virtually, RetroSense focuses on securing top industry talent for its specialized needs, showcasing a flexible, determined, and innovative culture.

Taxonomy: Gene therapy, Vision restoration, Retinal degeneration, Drug development, Startup success, Optogenetics, Photosensitivity gene, Channelrhodopsin-2, Wayne State University, Retinitis pigmentosa, Age-related macular degeneration, Agile company, Innovative thinking, Research and development

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Series B $6.00M 5
ExSight Ventures BlueWater Angels RBV Capital
ExSight Ventures, BlueWater Angels +3
12 Nov 2015
Private Equity Round $5.00M -
31 Aug 2015
Series A $6.00M 5
Tech Coast Angels BlueWater Angels Michigan Economic Development Corporation
Tech Coast Angels, BlueWater Angels +3
08 Jan 2015
Seed Round Undisclosed -
11 Jul 2011
Venture Round Undisclosed -
04 Mar 2011

RetroSense Therapeutics Alternatives & Competitors

View All Alternatives
RetroSense Therapeutics vs
CiRC Biosciences
CiRC Biosciences United States

A privately held, cell therapy company, developing treatments for serious diseases, with an initial...

Debt Financing
12 employees
Biotechnology, Health and Wellness
RetroSense Therapeutics vs
Ray Therapeutics, Inc.
Ray Therapeutics, Inc. United States

Optogenetic Gene Therapy Company

Series B
46 employees
Biotechnology, Health Care
RetroSense Therapeutics vs
Beacon Therapeutics
Beacon Therapeutics United Kingdom

Transforming Vision, Transforming Lives

Series C
95 employees
Biotechnology, Health Care
View all alternatives

FAQ About RetroSense Therapeutics

Led by a team of seasoned veterans, RetroSense Therapeutics was founded in 2009 to develop a novel gene therapy approach to vision restoration. RetroSense is located in Ann Arbor, Michigan, a short drive from Wayne State University, where the approach was pioneered. RetroSense has secured exclusive,...
RetroSense Therapeutics was founded in 2009.
RetroSense Therapeutics operates in Biotechnology, Health and Wellness and Life Sciences. Its work centres on Gene therapy, Vision restoration, Retinal degeneration and Drug development.
RetroSense Therapeutics has approximately 1 employees.
RetroSense Therapeutics has completed 5 funding rounds, raising a total of $17.00M. The latest funding stage is Series B.
Top alternatives and competitors to RetroSense Therapeutics include CiRC Biosciences, Ray Therapeutics, Inc., Beacon Therapeutics, FELIQS, ONL Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
RetroSense Therapeutics and CiRC Biosciences are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for RetroSense Therapeutics, https://bouncewatch.com/company/retrosense-therapeutics, updated 27 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes